Pregnancy [clinicaltrials_resource:0b1e9b6d66687ace5eb791ea2ac5a3c8]
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns [clinicaltrials:NCT00000642]A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) [clinicaltrials:NCT00000751]Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo) [clinicaltrials:NCT00000777]A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers [clinicaltrials:NCT00000808]Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine [clinicaltrials:NCT00000828]Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells. [clinicaltrials:NCT00000830]A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women [clinicaltrials:NCT00000839]A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women [clinicaltrials:NCT00000862]A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies [clinicaltrials:NCT00000869]A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000878]A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000887]Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies [clinicaltrials:NCT00000888]A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies [clinicaltrials:NCT00000910]Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants [clinicaltrials:NCT00000917]Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [clinicaltrials:NCT00000920]A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies [clinicaltrials:NCT00000942]A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000944]The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants [clinicaltrials:NCT00000960]Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) [clinicaltrials:NCT00001041]Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) [clinicaltrials:NCT00001046]A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children [clinicaltrials:NCT00001106]A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants [clinicaltrials:NCT00001135]Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status [clinicaltrials:NCT00001376]Hormonal Effects on the Uterus and Endometrium [clinicaltrials:NCT00001454]Effect of Pregnancy on Uveitis [clinicaltrials:NCT00001867]Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor [clinicaltrials:NCT00011622]Study for Future Families [clinicaltrials:NCT00011687]Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation [clinicaltrials:NCT00013793]Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy [clinicaltrials:NCT00017719]Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women [clinicaltrials:NCT00017797]A Study of HIV Levels During Pregnancy and After Childbirth [clinicaltrials:NCT00041964]Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS. [clinicaltrials:NCT00044603]The Maternal Lifestyle Study (MLS) [clinicaltrials:NCT00059540]Increased Access to Emergency Contraceptive Pills [clinicaltrials:NCT00060463]Providing Birth Control Through Home Health Visits [clinicaltrials:NCT00065078]Effectiveness of BufferGel as a Vaginal Contraceptive [clinicaltrials:NCT00065858]Prenatal Testing: Amniocentesis Versus Transabdominal Chorionic Villus Sampling (TA CVS) [clinicaltrials:NCT00065897]Studying Fetal Breathing Patterns [clinicaltrials:NCT00066976]Emergency Contraception (ECP): Reducing Unintended Pregnancies [clinicaltrials:NCT00067509]Preventing Unplanned Pregnancies in HIV Infected Zambian Couples [clinicaltrials:NCT00067522]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT01567085 [clinicaltrials_resource:03de412350d9c1b456ab579010549ace]eligibility for clinicaltrials:NCT00576836 [clinicaltrials_resource:0f8606c0a9c0dad66865eb2fbb6d17ce]eligibility for clinicaltrials:NCT02350491 [clinicaltrials_resource:256e3081744f0bbc0cd4c04050ad83e9]eligibility for clinicaltrials:NCT00120783 [clinicaltrials_resource:35c9449c54cd7bdce75e5ff27569b642]eligibility for clinicaltrials:NCT00548041 [clinicaltrials_resource:4e446fccc9cd42a5801690064ca6a8e4]eligibility for clinicaltrials:NCT00465998 [clinicaltrials_resource:5742d9947cd8a0f8f8cd7b7566db9d9c]eligibility for clinicaltrials:NCT00534105 [clinicaltrials_resource:5a3228f4fe9e82b756a3e37eed05c677]eligibility for clinicaltrials:NCT02261012 [clinicaltrials_resource:5c99023f4e35f618e6bc656ed374924e]eligibility for clinicaltrials:NCT00129324 [clinicaltrials_resource:610f3fbf8155d4359aa512cf7217c998]eligibility for clinicaltrials:NCT01578629 [clinicaltrials_resource:9a3fdc7274bd0bd3fcfb92f38b113583]eligibility for clinicaltrials:NCT00967382 [clinicaltrials_resource:a61e0dafca2dd2f476c6e775c129f4fd]eligibility for clinicaltrials:NCT00737516 [clinicaltrials_resource:db1f20c7ea0a85ba7f81b8e7bf0f1475]eligibility for clinicaltrials:NCT00610558 [clinicaltrials_resource:dc10ffa41f4087c1bbaa85b91eb812fb]eligibility for clinicaltrials:NCT01115140 [clinicaltrials_resource:dc9d2f12b51b00492fc08b9b133abd25]eligibility for clinicaltrials:NCT02180620 [clinicaltrials_resource:f42e44643a3d96dea2fb087242b0bf65]eligibility for clinicaltrials:NCT01745822 [clinicaltrials_resource:f544f9c20aa383bf08c8698cc9286f5e]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01039545 [clinicaltrials_resource:02ee222929b72e4a74dc292b4710ae95]eligibility for clinicaltrials:NCT01567085 [clinicaltrials_resource:03de412350d9c1b456ab579010549ace]eligibility for clinicaltrials:NCT02119000 [clinicaltrials_resource:05851b004973d37a0fa73f6916848bdf]eligibility for clinicaltrials:NCT00907998 [clinicaltrials_resource:0a240f740fb2a228ef5657925ba70ad7]eligibility for clinicaltrials:NCT02149901 [clinicaltrials_resource:0ede532e158658a739ecc4c64acff416]eligibility for clinicaltrials:NCT01436344 [clinicaltrials_resource:0f5cc160488ee3c0b98caa9aa0233749]eligibility for clinicaltrials:NCT00576836 [clinicaltrials_resource:0f8606c0a9c0dad66865eb2fbb6d17ce]eligibility for clinicaltrials:NCT01781494 [clinicaltrials_resource:14f1aef6b407b23548e790a641aa3fc7]eligibility for clinicaltrials:NCT00084136 [clinicaltrials_resource:1a402f5ad92e2931121afb10e44298d2]eligibility for clinicaltrials:NCT01521312 [clinicaltrials_resource:22b88aa22ebf04654397051099a2ec2d]eligibility for clinicaltrials:NCT02350491 [clinicaltrials_resource:256e3081744f0bbc0cd4c04050ad83e9]eligibility for clinicaltrials:NCT00419965 [clinicaltrials_resource:29b877f78b9ec12e9a573e01513b41c6]eligibility for clinicaltrials:NCT02258919 [clinicaltrials_resource:2bcb104d6a36f25685bef4cfc7d77874]eligibility for clinicaltrials:NCT01544361 [clinicaltrials_resource:30219e151f97b34203d2f6c2d99795bc]eligibility for clinicaltrials:NCT00538317 [clinicaltrials_resource:3173002a24a645edd031a8be80a9607d]eligibility for clinicaltrials:NCT02139254 [clinicaltrials_resource:31810cf2de3a4d873beeeb80783eb829]eligibility for clinicaltrials:NCT00299403 [clinicaltrials_resource:3460c48cd5f19a31228f3bd3d971a381]eligibility for clinicaltrials:NCT00064532 [clinicaltrials_resource:35459559ba93e0943ad9c485af944c30]eligibility for clinicaltrials:NCT00120783 [clinicaltrials_resource:35c9449c54cd7bdce75e5ff27569b642]eligibility for clinicaltrials:NCT00971178 [clinicaltrials_resource:3b81e1ebfc60dd83d305b79ff8ef430c]eligibility for clinicaltrials:NCT02400268 [clinicaltrials_resource:402be5ba0f9ee52b6a5091adbcfa128e]eligibility for clinicaltrials:NCT02028260 [clinicaltrials_resource:42992ff4229ebdaf12767ac39ab7aa64]eligibility for clinicaltrials:NCT00048802 [clinicaltrials_resource:42f01967cb441853a43356785d994a6f]eligibility for clinicaltrials:NCT01808846 [clinicaltrials_resource:45e3bc868f0b8fe504b6aee9c0f01035]eligibility for clinicaltrials:NCT01575795 [clinicaltrials_resource:471ed10ffe5b3c252d207e030bf87906]eligibility for clinicaltrials:NCT01276665 [clinicaltrials_resource:4747d65228dba99ece6ccf15d45d61e5]eligibility for clinicaltrials:NCT00976313 [clinicaltrials_resource:48003d0b66437072340b7c28b61e3d63]eligibility for clinicaltrials:NCT01887899 [clinicaltrials_resource:4c51de71ca93347dd645f6e03e312998]eligibility for clinicaltrials:NCT00548041 [clinicaltrials_resource:4e446fccc9cd42a5801690064ca6a8e4]eligibility for clinicaltrials:NCT00201409 [clinicaltrials_resource:556f60fa21601204277d2b2c8b0ca04c]eligibility for clinicaltrials:NCT00465998 [clinicaltrials_resource:5742d9947cd8a0f8f8cd7b7566db9d9c]eligibility for clinicaltrials:NCT00680771 [clinicaltrials_resource:586b5b3b8277233ea411251ceb0b6694]eligibility for clinicaltrials:NCT00534105 [clinicaltrials_resource:5a3228f4fe9e82b756a3e37eed05c677]eligibility for clinicaltrials:NCT01404845 [clinicaltrials_resource:5bfa588a6132bf11caa817de62e225d2]eligibility for clinicaltrials:NCT00300729 [clinicaltrials_resource:5c951b4def9cc43b2eb2b9a8d4aa83c8]eligibility for clinicaltrials:NCT02261012 [clinicaltrials_resource:5c99023f4e35f618e6bc656ed374924e]eligibility for clinicaltrials:NCT01954849 [clinicaltrials_resource:5d4dfc6979bf741100aa089b9d40a96c]eligibility for clinicaltrials:NCT00129324 [clinicaltrials_resource:610f3fbf8155d4359aa512cf7217c998]eligibility for clinicaltrials:NCT00993460 [clinicaltrials_resource:6128459c1a394359940ffd9fde19e6cd]eligibility for clinicaltrials:NCT01009398 [clinicaltrials_resource:620d2bc1fedc86f1f908b06067318360]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Pregnancy [clinicaltrials_resource:0b1e9b6d66687ace5eb791ea2ac5a3c8]
Bio2RDF identifier
0b1e9b6d66687ace5eb791ea2ac5a3c8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0b1e9b6d66687ace5eb791ea2ac5a3c8
identifier
clinicaltrials_resource:0b1e9b6d66687ace5eb791ea2ac5a3c8
title
Pregnancy
@en
type
label
Pregnancy [clinicaltrials_resource:0b1e9b6d66687ace5eb791ea2ac5a3c8]
@en